Suppliers of rapid antigen tests say the federal government is shorting the stock of the hard-to-find tests, while they scramble to fulfil up to 90,000 back-orders.
While policymakers didn’t necessarily foresee the sudden emergence of a more transmissible, less virulent strain of COVID-19, some experts say we could have been better prepared to face the economic havoc created by Omicron.